Nifty

:

25330.25

Sensex

:

82693.71

91.15 (0.36%)
313.02 (0.38%)

Login

Nifty
Sensex

:
:

25330.25
82693.71

91.15 (0.36%)
313.02 (0.38%)

Neuland Laboratories Ltd.

Pharmaceuticals & Drugs - API

Rating :

61/99

BSE: 524558 | NSE: NEULANDLAB

Watchlist

NSE BSE

16156.00

17-Sep-2025

Open
High
Low
Previous Close

16250
16300
15962
16221.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

35348
569977563
18100
10190.7

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

20,712.06
117.59
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

20,589.25
0.07%
13.47

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.22
9.53
7.43

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.92
17.10
3.53

PAT CAGR (%)

10 Years
5 Years
3 Years

25.27
26.40
16.73

P:E (Median)

8 Years
5 Years
3 Years

32.84
29.08
28.54

P:BV (Average)

8 Years
5 Years
3 Years

4.18
5.37
7.28

EV:EBITDA (Average)

8 Years
5 Years
3 Years

18.60
21.29
25.98

Earnings Forecasts:

(Updated: 16-09-2025)

Description 2024 2025 2026 2027
Adj EPS 201.63 222.05 372.25 451.92
P/E Ratio 80.13 72.76 43.40 35.75
Revenue 1434.38 1077.25 1416.05 2598.8
EBITDA 323.26 286.55 493.6 831.6
Net Income 260.11 285.8 478.9 581.45
ROA 12.97
P/B Ratio 13.59 11.23 8.92 7.11
ROE 18.53 17.13 23.41 22.62
FCFF 113.21 -88.8 177.74 298.47
FCFF Yield 0.6 -0.47 0.95 1.59
Net Debt -209.36
BVPS 1188.48 1438.47 1810.56 2271.69

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 292.75 439.60 -33.41% 328.36 385.01 -14.71% 398.03 392.83 1.32% 310.84 417.75 -25.59%
Expenses 258.46 315.78 -18.15% 277.61 278.22 -0.22% 311.66 272.26 14.47% 249.50 280.45 -11.04%
EBITDA 34.29 123.83 -72.31% 50.75 106.79 -52.48% 86.38 120.56 -28.35% 61.34 137.30 -55.32%
EBIDTM 11.71% 28.17% 15.46% 27.74% 21.70% 30.69% 19.73% 32.87%
Other Income 7.86 4.81 63.41% 7.46 5.36 39.18% 3.91 2.10 86.19% 4.33 3.05 41.97%
Interest 4.58 2.67 71.54% 2.35 3.61 -34.90% 2.22 3.74 -40.64% 1.06 4.43 -76.07%
Depreciation 20.19 16.28 24.02% 16.89 16.46 2.61% 16.30 15.14 7.66% 16.07 14.51 10.75%
PBT 17.38 130.31 -86.66% 38.98 92.08 -57.67% 127.55 103.78 22.90% 48.54 121.41 -60.02%
Tax 3.67 31.97 -88.52% 11.25 24.47 -54.03% 26.15 23.08 13.30% 16.58 32.34 -48.73%
PAT 13.71 98.34 -86.06% 27.73 67.61 -58.99% 101.39 80.70 25.64% 31.96 89.06 -64.11%
PATM 4.68% 22.37% 8.45% 17.56% 25.47% 20.54% 10.28% 21.32%
EPS 10.71 76.83 -86.06% 21.67 52.82 -58.97% 79.21 63.05 25.63% 24.97 69.58 -64.11%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 292.75 439.60 -33.41% 328.36 385.01 -14.71% 398.03 392.83 1.32% 310.84 417.75 -25.59%
Expenses 258.26 316.24 -18.33% 277.29 278.09 -0.29% 311.43 271.56 14.68% 248.62 280.26 -11.29%
EBITDA 34.49 123.36 -72.04% 51.07 106.92 -52.24% 86.60 121.27 -28.59% 62.23 137.49 -54.74%
EBIDTM 11.78% 28.06% 15.55% 27.77% 21.76% 30.87% 20.02% 32.91%
Other Income 7.86 4.81 63.41% 7.46 5.36 39.18% 3.91 2.10 86.19% 4.33 3.05 41.97%
Interest 4.59 2.67 71.91% 2.35 3.61 -34.90% 2.22 3.74 -40.64% 1.06 4.43 -76.07%
Depreciation 20.19 16.28 24.02% 16.89 16.46 2.61% 16.30 15.14 7.66% 16.07 14.51 10.75%
PBT 17.57 129.84 -86.47% 39.30 92.20 -57.38% 127.77 104.48 22.29% 49.42 121.59 -59.36%
Tax 3.67 31.97 -88.52% 11.49 24.64 -53.37% 26.18 23.09 13.38% 16.58 32.35 -48.75%
PAT 13.90 97.87 -85.80% 27.80 67.56 -58.85% 101.59 81.39 24.82% 32.84 89.25 -63.20%
PATM 4.75% 22.26% 8.47% 17.55% 25.52% 20.72% 10.57% 21.36%
EPS 10.77 75.86 -85.80% 21.55 52.37 -58.85% 78.75 63.09 24.82% 25.46 69.18 -63.20%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,329.98 1,476.84 1,558.58 1,191.20 951.08 936.91 762.71 666.83 527.41 578.89 509.97 Net Sales Growth -18.67% -5.24% 30.84% 25.25% 1.51% 22.84% 14.38% 26.43% -8.89% 13.51% Cost Of Goods Sold 524.29 587.64 577.29 478.23 422.14 438.42 380.20 366.24 238.37 262.90 253.46 Gross Profit 805.69 889.20 981.30 712.97 528.94 498.50 382.51 300.59 289.04 315.99 256.52 GP Margin 60.58% 60.21% 62.96% 59.85% 55.61% 53.21% 50.15% 45.08% 54.80% 54.59% 50.30% Total Expenditure 1,097.23 1,154.54 1,096.66 919.89 808.88 790.47 661.25 608.96 477.38 473.20 430.10 Power & Fuel Cost - 50.56 48.72 48.62 42.21 39.21 32.75 26.81 25.95 25.78 22.24 % Of Sales - 3.42% 3.13% 4.08% 4.44% 4.19% 4.29% 4.02% 4.92% 4.45% 4.36% Employee Cost - 261.40 248.53 194.84 175.76 144.02 118.48 104.47 95.73 84.92 59.89 % Of Sales - 17.70% 15.95% 16.36% 18.48% 15.37% 15.53% 15.67% 18.15% 14.67% 11.74% Manufacturing Exp. - 112.31 107.79 86.94 89.16 77.10 64.84 50.10 55.54 44.90 39.31 % Of Sales - 7.60% 6.92% 7.30% 9.37% 8.23% 8.50% 7.51% 10.53% 7.76% 7.71% General & Admin Exp. - 78.46 68.84 48.24 34.50 37.42 25.18 24.56 30.38 25.23 26.90 % Of Sales - 5.31% 4.42% 4.05% 3.63% 3.99% 3.30% 3.68% 5.76% 4.36% 5.27% Selling & Distn. Exp. - 42.06 35.45 40.25 36.00 42.38 26.59 28.01 26.50 23.14 26.41 % Of Sales - 2.85% 2.27% 3.38% 3.79% 4.52% 3.49% 4.20% 5.02% 4.00% 5.18% Miscellaneous Exp. - 22.11 10.04 22.77 9.12 11.93 13.21 8.76 4.91 6.34 26.41 % Of Sales - 1.50% 0.64% 1.91% 0.96% 1.27% 1.73% 1.31% 0.93% 1.10% 0.37% EBITDA 232.76 322.30 461.92 271.31 142.20 146.44 101.46 57.87 50.03 105.69 79.87 EBITDA Margin 17.50% 21.82% 29.64% 22.78% 14.95% 15.63% 13.30% 8.68% 9.49% 18.26% 15.66% Other Income 23.56 20.51 12.54 9.75 2.08 16.09 3.89 3.49 4.53 1.17 1.62 Interest 10.21 8.30 14.00 13.07 13.49 17.90 21.57 15.66 18.92 21.08 24.47 Depreciation 69.45 65.54 59.70 52.78 49.04 39.68 31.28 25.86 22.10 19.23 15.74 PBT 232.45 268.97 400.77 215.21 81.74 104.96 52.50 19.84 13.54 66.55 41.28 Tax 57.65 85.95 101.17 52.09 18.21 24.67 36.62 3.69 1.73 20.17 14.87 Tax Rate 24.80% 24.89% 25.24% 24.20% 22.28% 23.50% 69.75% 18.60% 12.78% 30.31% 36.02% PAT 174.79 259.43 299.60 163.12 63.53 80.29 15.88 16.14 11.81 46.38 26.41 PAT before Minority Interest 174.79 259.43 299.60 163.12 63.53 80.29 15.88 16.14 11.81 46.38 26.41 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.14% 17.57% 19.22% 13.69% 6.68% 8.57% 2.08% 2.42% 2.24% 8.01% 5.18% PAT Growth -47.93% -13.41% 83.67% 156.76% -20.87% 405.60% -1.61% 36.66% -74.54% 75.62% EPS 136.55 202.68 234.06 127.44 49.63 62.73 12.41 12.61 9.23 36.23 20.63

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,329.98 1,476.84 1,558.58 1,191.20 951.08 936.91 762.71 666.83 527.41 578.89 509.97 Net Sales Growth -18.67% -5.24% 30.84% 25.25% 1.51% 22.84% 14.38% 26.43% -8.89% 13.51% Cost Of Goods Sold 524.29 587.64 577.29 478.23 422.14 438.42 380.20 366.24 238.37 262.90 253.46 Gross Profit 805.69 889.20 981.30 712.97 528.94 498.50 382.51 300.59 289.04 315.99 256.52 GP Margin 60.58% 60.21% 62.96% 59.85% 55.61% 53.21% 50.15% 45.08% 54.80% 54.59% 50.30% Total Expenditure 1,095.60 1,153.58 1,095.99 919.36 808.46 790.09 660.82 608.46 476.98 472.55 429.52 Power & Fuel Cost - 50.56 48.72 48.62 42.21 39.21 32.75 26.81 25.95 25.78 22.24 % Of Sales - 3.42% 3.13% 4.08% 4.44% 4.19% 4.29% 4.02% 4.92% 4.45% 4.36% Employee Cost - 272.00 257.06 201.79 182.47 149.74 123.56 110.46 102.99 92.74 65.38 % Of Sales - 18.42% 16.49% 16.94% 19.19% 15.98% 16.20% 16.56% 19.53% 16.02% 12.82% Manufacturing Exp. - 112.31 107.79 86.94 89.16 77.10 64.84 50.10 55.54 44.90 39.31 % Of Sales - 7.60% 6.92% 7.30% 9.37% 8.23% 8.50% 7.51% 10.53% 7.76% 7.71% General & Admin Exp. - 67.29 60.91 51.22 35.80 38.93 27.75 27.49 33.32 28.30 29.72 % Of Sales - 4.56% 3.91% 4.30% 3.76% 4.16% 3.64% 4.12% 6.32% 4.89% 5.83% Selling & Distn. Exp. - 41.35 33.94 29.58 27.40 34.63 18.30 18.28 14.04 11.16 17.52 % Of Sales - 2.80% 2.18% 2.48% 2.88% 3.70% 2.40% 2.74% 2.66% 1.93% 3.44% Miscellaneous Exp. - 22.42 10.29 22.99 9.28 12.08 13.42 9.08 6.77 6.78 17.52 % Of Sales - 1.52% 0.66% 1.93% 0.98% 1.29% 1.76% 1.36% 1.28% 1.17% 0.37% EBITDA 234.39 323.26 462.59 271.84 142.62 146.82 101.89 58.37 50.43 106.34 80.45 EBITDA Margin 17.62% 21.89% 29.68% 22.82% 15.00% 15.67% 13.36% 8.75% 9.56% 18.37% 15.78% Other Income 23.56 20.51 12.54 9.75 2.08 16.10 3.89 3.49 4.53 1.17 1.78 Interest 10.22 8.30 14.00 13.07 13.50 17.90 21.57 15.66 18.93 21.09 24.48 Depreciation 69.45 65.55 59.70 52.78 49.04 39.68 31.28 25.86 22.10 19.23 15.74 PBT 234.06 269.93 401.44 215.75 82.16 105.33 52.92 20.34 13.93 67.19 42.00 Tax 57.92 86.22 101.36 52.23 18.34 24.70 36.71 3.90 1.87 20.32 14.92 Tax Rate 24.75% 24.90% 25.25% 24.21% 22.32% 23.45% 69.37% 19.17% 13.42% 30.24% 35.52% PAT 176.13 260.11 300.08 163.52 63.82 80.63 16.21 16.44 12.06 46.86 27.33 PAT before Minority Interest 176.13 260.11 300.08 163.52 63.82 80.63 16.21 16.44 12.06 46.86 27.08 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.25 PAT Margin 13.24% 17.61% 19.25% 13.73% 6.71% 8.61% 2.13% 2.47% 2.29% 8.09% 5.36% PAT Growth -47.59% -13.32% 83.51% 156.22% -20.85% 397.41% -1.40% 36.32% -74.26% 71.46% EPS 137.60 203.21 234.44 127.75 49.86 62.99 12.66 12.84 9.42 36.61 21.35

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,517.79 1,276.54 988.36 835.57 781.88 705.55 695.58 554.78 542.78 184.17 Share Capital 12.90 12.90 12.90 12.90 12.90 12.90 12.90 8.95 8.95 8.95 Total Reserves 1,504.89 1,263.64 975.46 822.67 768.98 692.64 682.68 234.98 222.97 175.22 Non-Current Liabilities 187.54 120.59 145.22 178.42 168.68 162.21 103.13 145.78 53.83 69.01 Secured Loans 90.73 44.92 74.25 104.25 88.13 77.37 60.72 103.49 29.81 33.40 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.00 Long Term Provisions 6.64 7.13 9.83 11.45 9.10 12.18 11.74 9.87 9.28 6.85 Current Liabilities 472.84 433.80 445.75 368.13 372.96 361.99 331.19 370.38 288.24 270.16 Trade Payables 260.90 198.54 177.99 122.65 156.75 120.00 124.00 129.01 88.64 86.17 Other Current Liabilities 209.84 233.63 244.71 152.05 158.59 71.55 57.33 40.57 47.11 54.90 Short Term Borrowings 0.00 0.00 11.16 92.21 56.98 168.17 149.06 199.20 151.08 123.63 Short Term Provisions 2.10 1.64 11.89 1.21 0.64 2.27 0.80 1.59 1.41 5.47 Total Liabilities 2,178.17 1,830.93 1,579.33 1,382.12 1,323.52 1,229.75 1,129.90 1,070.94 884.85 523.34 Net Block 954.89 804.63 738.19 747.70 696.92 622.75 511.67 445.01 435.74 138.77 Gross Block 1,238.17 1,069.73 953.24 913.24 826.45 714.31 575.42 483.45 454.74 291.78 Accumulated Depreciation 283.28 265.10 215.05 165.54 129.53 91.56 63.75 38.44 19.00 153.00 Non Current Assets 1,040.35 911.46 819.00 802.87 775.34 715.91 676.96 624.22 510.60 210.00 Capital Work in Progress 47.66 45.89 40.57 20.46 17.25 23.75 104.47 126.09 19.60 40.48 Non Current Investment 1.69 1.44 0.68 0.66 19.50 30.33 30.37 30.37 30.36 7.55 Long Term Loans & Adv. 35.88 40.31 20.21 14.40 41.66 35.78 30.45 22.52 24.69 22.71 Other Non Current Assets 0.23 0.17 0.00 0.00 0.00 3.30 0.00 0.22 0.22 0.50 Current Assets 1,137.82 919.47 760.34 579.25 548.18 513.83 452.93 446.73 374.24 313.34 Current Investments 107.68 0.00 0.00 3.38 6.46 7.50 7.50 7.50 7.50 0.00 Inventories 385.76 350.42 279.23 265.21 247.61 219.55 192.65 175.09 135.11 126.66 Sundry Debtors 315.72 373.53 361.77 234.33 217.73 189.89 164.02 193.92 181.11 119.11 Cash & Bank 257.27 115.29 58.65 18.99 18.08 45.69 37.35 17.05 12.04 9.04 Other Current Assets 71.39 18.27 13.66 11.39 58.30 51.21 51.41 53.17 38.47 58.53 Short Term Loans & Adv. 51.75 61.96 47.03 45.95 49.54 33.79 31.77 36.93 25.03 46.54 Net Current Assets 664.98 485.67 314.59 211.12 175.22 151.84 121.74 76.35 86.00 43.18 Total Assets 2,178.17 1,830.93 1,579.34 1,382.12 1,323.52 1,229.74 1,129.89 1,070.95 884.84 523.34

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,524.81 1,282.70 994.10 840.50 786.46 709.96 699.31 558.04 545.62 186.63 Share Capital 12.90 12.90 12.90 12.90 12.90 12.90 12.90 8.95 8.95 8.95 Total Reserves 1,511.91 1,269.80 981.20 827.60 773.56 697.06 686.41 238.24 225.81 177.68 Non-Current Liabilities 189.39 122.17 146.71 179.83 169.82 163.39 104.06 146.43 54.37 69.42 Secured Loans 90.73 44.92 74.25 104.25 88.13 77.37 60.72 103.49 29.81 33.40 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.00 Long Term Provisions 7.22 7.61 10.29 11.91 9.44 12.49 11.91 9.87 9.28 6.85 Current Liabilities 465.69 427.68 438.96 363.16 368.51 357.63 326.98 366.93 285.60 268.00 Trade Payables 252.20 191.96 171.01 117.38 152.13 115.56 119.68 124.29 85.92 83.86 Other Current Liabilities 211.30 234.01 244.87 152.35 158.75 71.63 57.45 41.83 47.18 55.02 Short Term Borrowings 0.00 0.00 11.16 92.21 56.98 168.17 149.06 199.20 151.08 123.63 Short Term Provisions 2.19 1.72 11.93 1.21 0.64 2.27 0.80 1.59 1.41 5.50 Total Liabilities 2,179.89 1,832.55 1,579.77 1,383.49 1,324.79 1,230.98 1,130.35 1,071.40 885.59 524.05 Net Block 954.92 804.64 738.19 747.70 696.94 622.76 511.69 445.01 435.74 138.77 Gross Block 1,238.23 1,069.76 950.36 913.27 826.48 714.33 575.44 483.45 454.74 291.78 Accumulated Depreciation 283.31 265.12 212.17 165.57 129.54 91.57 63.75 38.44 19.00 153.00 Non Current Assets 1,040.38 911.48 818.87 802.70 775.20 715.79 676.88 624.20 510.54 209.87 Capital Work in Progress 47.66 45.89 40.57 20.46 17.25 23.75 104.47 126.09 19.60 40.48 Non Current Investment 1.53 1.28 0.52 0.50 19.35 30.17 30.21 30.21 30.20 7.39 Long Term Loans & Adv. 36.04 40.47 20.24 14.38 41.67 35.81 30.51 22.66 24.79 22.73 Other Non Current Assets 0.23 0.17 0.00 0.00 0.00 3.30 0.00 0.22 0.22 0.50 Current Assets 1,139.50 921.08 760.89 580.79 549.59 515.19 453.47 447.19 375.04 314.19 Current Investments 107.68 0.00 0.00 3.38 6.46 7.50 7.50 7.50 7.50 0.00 Inventories 385.76 350.42 279.23 265.21 247.61 219.55 192.65 175.09 135.11 126.66 Sundry Debtors 315.72 373.53 361.77 234.33 217.73 189.89 164.02 193.92 181.11 119.11 Cash & Bank 258.82 116.80 59.10 20.36 19.40 46.98 37.84 17.26 12.49 9.71 Other Current Assets 71.52 18.30 13.70 11.52 58.39 51.27 51.46 53.43 38.83 58.70 Short Term Loans & Adv. 51.82 62.03 47.09 46.00 49.55 33.80 31.77 37.15 25.30 46.68 Net Current Assets 673.81 493.40 321.94 217.64 181.08 157.55 126.49 80.27 89.45 46.18 Total Assets 2,179.88 1,832.56 1,579.76 1,383.49 1,324.79 1,230.98 1,130.35 1,071.39 885.58 524.06

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 317.49 260.06 238.53 60.41 189.28 56.63 69.60 11.52 38.89 44.65 PBT 345.37 400.77 215.21 81.74 104.96 52.50 19.84 13.54 66.55 41.28 Adjustment -12.01 62.07 77.93 66.18 40.17 58.14 38.93 40.35 43.95 33.85 Changes in Working Capital 58.75 -91.22 -11.04 -66.99 49.34 -49.30 15.92 -39.20 -55.25 -18.76 Cash after chg. in Working capital 392.11 371.63 282.10 80.93 194.47 61.33 74.68 14.69 55.25 56.38 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -74.62 -111.57 -43.57 -20.53 -5.19 -4.70 -5.09 -3.17 -16.36 -11.73 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -298.14 -149.67 -61.50 -95.53 -84.42 -48.68 -77.22 -116.29 -42.11 -19.86 Net Fixed Assets -170.21 -121.81 -60.11 -90.00 -105.64 -58.17 -70.35 -135.20 -142.08 -27.14 Net Investments -107.93 -0.76 3.36 21.92 11.87 0.04 0.00 -0.01 -30.31 0.12 Others -20.00 -27.10 -4.75 -27.45 9.35 9.45 -6.87 18.92 130.28 7.16 Cash from Financing Activity 24.96 -69.28 -135.80 37.72 -113.66 -5.48 11.98 104.86 -0.08 -23.62 Net Cash Inflow / Outflow 44.31 41.11 41.24 2.60 -8.80 2.47 4.36 0.09 -3.30 1.18 Opening Cash & Equivalents 86.07 44.96 3.72 1.12 9.92 7.44 3.08 3.00 6.29 0.32 Closing Cash & Equivalent 130.38 86.07 44.96 3.72 1.12 9.92 7.44 3.08 3.00 1.49

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 317.38 261.18 237.21 60.39 189.36 57.34 69.91 11.27 38.68 44.83 PBT 346.33 401.44 215.75 82.16 105.33 52.92 20.34 13.93 67.19 42.00 Adjustment -12.00 62.08 77.93 66.30 40.08 58.28 39.11 40.43 43.96 33.73 Changes in Working Capital 57.78 -90.73 -12.83 -67.58 49.22 -49.17 15.47 -40.02 -55.94 -19.17 Cash after chg. in Working capital 392.11 372.78 280.84 80.88 194.63 62.03 74.91 14.35 55.20 56.56 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -74.73 -111.60 -43.63 -20.49 -5.27 -4.68 -5.01 -3.08 -16.52 -11.73 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -298.16 -149.69 -61.50 -95.52 -84.42 -48.68 -77.23 -116.29 -42.11 -19.86 Net Fixed Assets -170.21 -121.81 -60.11 -90.00 -105.64 -58.17 -70.35 -135.20 -142.08 -27.14 Net Investments -107.93 -0.76 3.36 21.92 11.87 0.04 0.00 -0.01 -30.31 0.12 Others -20.02 -27.12 -4.75 -27.44 9.35 9.45 -6.88 18.92 130.28 7.16 Cash from Financing Activity 24.96 -69.28 -135.80 37.72 -113.66 -5.48 11.98 104.85 -0.09 -23.62 Net Cash Inflow / Outflow 44.19 42.21 39.92 2.59 -8.72 3.18 4.66 -0.17 -3.51 1.35 Opening Cash & Equivalents 87.58 45.42 5.09 2.44 11.20 7.94 3.29 3.44 6.97 0.81 Closing Cash & Equivalent 131.93 87.58 45.42 5.09 2.44 11.20 7.94 3.29 3.44 2.16

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 1182.30 994.26 769.65 650.56 608.71 549.21 541.45 273.54 260.03 206.30 ROA 12.94% 17.57% 11.02% 4.70% 6.29% 1.35% 1.47% 1.21% 6.59% 5.11% ROE 18.58% 26.48% 17.90% 7.86% 10.81% 2.27% 3.44% 4.98% 22.39% 15.44% ROCE 23.49% 33.62% 20.99% 9.44% 12.83% 7.84% 3.95% 4.04% 15.94% 18.46% Fixed Asset Turnover 1.28 1.54 1.28 1.09 1.22 1.18 1.26 1.13 1.57 1.86 Receivable days 85.17 86.10 91.33 86.74 79.40 84.68 97.96 129.34 93.22 87.45 Inventory Days 90.97 73.73 83.41 98.40 91.00 98.63 100.64 106.98 81.29 84.66 Payable days 142.69 119.04 114.73 120.79 115.20 67.56 78.05 84.05 68.43 85.33 Cash Conversion Cycle 33.46 40.79 60.01 64.36 55.20 115.76 120.56 152.27 106.08 86.78 Total Debt/Equity 0.09 0.06 0.12 0.28 0.22 0.37 0.33 1.31 0.83 0.99 Interest Cover 42.63 29.63 17.47 7.06 6.86 3.43 2.27 1.72 4.16 2.69

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 1187.77 999.07 774.12 654.40 612.28 552.65 544.35 277.21 263.23 209.07 ROA 12.97% 17.59% 11.04% 4.71% 6.31% 1.37% 1.49% 1.23% 6.65% 5.23% ROE 18.54% 26.38% 17.84% 7.85% 10.79% 2.30% 3.48% 5.02% 22.34% 15.64% ROCE 23.45% 33.51% 20.94% 9.44% 12.81% 7.85% 3.99% 4.07% 15.98% 18.57% Fixed Asset Turnover 1.28 1.54 1.28 1.09 1.22 1.18 1.26 1.13 1.57 1.86 Receivable days 85.17 86.10 91.33 86.74 79.40 84.68 97.96 129.34 93.22 87.45 Inventory Days 90.97 73.73 83.41 98.40 91.00 98.63 100.64 106.98 81.29 84.66 Payable days 137.94 114.75 110.05 116.52 111.44 65.43 75.72 82.06 67.03 85.01 Cash Conversion Cycle 38.21 45.08 64.68 68.63 58.96 117.88 122.89 154.27 107.48 87.10 Total Debt/Equity 0.09 0.06 0.12 0.28 0.22 0.37 0.33 1.30 0.82 0.98 Interest Cover 42.74 29.68 17.51 7.09 6.89 3.45 2.30 1.74 4.19 2.72

Top Investors:

malabar india fund limited

mukul mahavir agrawal

hsbc balanced advantage fund

icici prudential s&p bse 500 etf

jupiter india fund

matthews india fund

kedia securities private limited

investor education and protection fund (iepf)

Annual Reports:

News Update:

Neuland Laboratories - Quarterly Results
31st Jul 2025, 16:21 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback